Families USA Comments to CMS on Medicare Drug Negotiation Guidance

The Centers for Medicare and Medicaid Services (CMS) released guidance on how they will implement future rounds of the Medicare drug negotiation process. Families USA submitted comments supporting several aspects of the guidance, as well as asking CMS to reassess certain decisions.

We believe it is critical for the experiences of the millions of people who rely on Medicare to access affordable prescription drugs to remain the focus of implementation efforts. To that end, our comments provided recommendations across the following areas:

1. Section 60.4: The negotiation process;

2. Section 60.3.2: Developing a starting point for the initial offer; and

3. Section 40.4: Providing access to the MFP for 2026 and 2027.

Click the download button below to view the Comment.